Polynucleotides Under the Eyes: What Is Known and the Risks

You look beneath your eyes in daylight: fine lines have appeared, the skin seems thinner and sometimes shadows remain even under concealer. Recommendations for polynucleotide injections around the eyes promise to “renew” the skin. They are most reasonably considered for changes in skin quality and fine lines—not as a universal treatment for dark circles, bags or deep hollows. Before choosing injections, identify what creates the appearance you dislike: pigment, visible vessels, missing volume, muscle movement, puffiness or the skin itself.

Polynucleotides (PN) are long fragments of nucleic acids used in some injectable aesthetic products. Researchers study whether they can improve particular skin measures, such as texture and elasticity. A shared category name does not mean every preparation has the same formula: concentration, added ingredients, intended area, instructions and evidence all vary. Discuss the full product name, composition and locally permitted use, not simply “polynucleotides under the eyes.”

Why can the same eye area look tired for very different reasons?

Lower-eyelid skin is thin, with vessels and muscles close beneath it; even small changes in volume or fluid retention show more clearly than on the cheek. The same bluish discoloration may come from visible vessels, natural pigment or a shadow at the eyelid–cheek junction. PN do not fill a deep tear trough as a volumizing filler does, nor relax a muscle like botulinum toxin. That is not a flaw: each intervention addresses a different problem.

Examine your face without makeup in diffuse light and then from the side. If a shadow changes with the direction of light, facial contours may play a role. If the color stays relatively constant, pigmentation and vessels deserve assessment. Morning changes, pillow marks, seasonal allergies or irritation from cosmetics suggest that swelling may contribute. This home observation is not a diagnosis; it helps you describe the pattern to a clinician.

A map of causes: what to discuss instead of a single “dark-circle injection”

What you notice	Possible cause	Where PN may fit and what to compare
Thin, somewhat dry skin with fine lines even at rest	Surface texture and elasticity changes	PN may be worth discussing with modest expectations; first review skin care and sun protection
Crow's feet when smiling	Contraction of the orbicularis oculi muscle	PN do not relax the muscle; discuss treatments for expression lines and their limitations separately
Blue undertone or vessels showing through	Thin skin and superficial vascular anatomy	Better texture does not guarantee vessels will disappear; investigate the cause
Brown circles or spots	Pigment, sometimes inflammation and rubbing	PN are not standard targeted pigment treatment; diagnosis and a gentle plan matter more
Hollow with a pronounced shadow in side lighting	Tear-trough anatomy and lost volume	PN do not restore structural volume; compare camouflage, observation or specialized correction
Bulge or puffiness that fluctuates	Fluid retention, fat pads, irritation or another condition	More injections can make swelling more visible; establish its origin first

Two or three factors often occur together. Skin may truly be thin, while a deep shadow creates most of the contrast in photographs. Even a noticeable gain in hydration may then leave the photographs largely unchanged. A good consultation separates the contribution of each factor rather than promising one course will remove everything.

What does evidence show specifically around the eyes?

A systematic review published on 10 October 2026 (searches through 30 January 2026) combined six studies of periorbital PN injections, involving 350 participants. It reported encouraging short-term changes in fine wrinkles and skin-quality measurements, but noted differing protocols, the small number of studies and no follow-up beyond six months. All six studies were conducted in Korea and Thailand, mostly among women with Fitzpatrick skin phototypes III–V; results cannot automatically be extended to every skin tone, age or product. They support cautious discussion, not a guaranteed individual outcome. An important distinction: much of the evidence concerns crow’s-feet lines at the outer corner of the eye. It does not by itself prove that PN injections eliminate dark circles, eye bags or hollows directly beneath the lower eyelid.

One small randomized study compared PN with non-cross-linked hyaluronic acid on opposite sides of the same face. Some instrument-measured results favored PN, while overall improvement ratings did not show a convincing difference. This supports a possible effect on skin quality but does not establish PN as the best treatment for every concern near the eyes. Products labeled PN or PDRN are not necessarily interchangeable.

Judge a promise by the outcome it measures. “My skin feels more hydrated,” “fine lines are less visible,” and “the dark tear trough disappeared” are three different outcomes. Ask the clinician to describe the goal plainly and agree beforehand how you will assess it: photographs taken in the same light, a defined area of skin, or less reliance on heavy concealer. If you want prominent bags to vanish entirely, PN are unlikely to address the main issue.

How might injections take place, and what can be seen afterward?

If treatment seems appropriate, the clinician examines the skin and eyelids and asks about allergies, previous injections, chronic conditions and medicines, then checks the product's ingredients and instructions. Injections can feel like brief pricks, pressure or burning. Topical anesthesia is sometimes used, depending on the product and circumstances. The injection sites, depth and intervals must be decided by a trained clinician; near the eyes, these are anatomical safety decisions, not a universal technique to copy from a video.

On treatment day, small papules—raised bumps at injection points—redness or localized puffiness may be visible. A bruise may develop later, and the thin lower eyelid makes it conspicuous even when you feel well. Some signs may settle by the next day, but nobody can promise the date when your face will look flawless. The response depends on technique, vessels, ingredients and personal tendency to swell. Ask when makeup is allowed and whether or how you can conceal marks.

Planning around how visible the recovery may be

Period	What may show	How to plan
Day of injection	Puncture marks, redness, bumps, tenderness	Do not count on a flawless close-up; follow personal aftercare instructions
Following days	Bruising or swelling, sometimes different on the two sides	Allow a buffer before filming, presentations or travel; ask the clinician about expected timing
Weeks later	Superficial marks are usually no longer the main issue, but the effect is still being assessed	Compare under the same light, without filters or pressure to rush into another injection
If symptoms worsen	Severe pain, changed vision, unusual skin color or inflammation	Do not wait for a routine appointment: seek urgent medical help

A modest cosmetic improvement may emerge gradually. The number of visits cannot be prescribed from the word “PN” alone; it depends on the exact product and goal. Do not commit to a prepaid lengthy course just because everyone supposedly does it. Agree on a review point and on when further injections should stop if there is no benefit.

Why are mistakes particularly consequential here?

The eye area calls for special care because it lies close to vessels connected with the eye’s blood supply. Injectables differ in their physical properties, so severe vascular complications documented with fillers cannot automatically be attributed to every PN product at the same frequency. Injections must nevertheless be performed by a qualified medical professional trained in the anatomy and in identifying complications. The US FDA warns of tissue necrosis, visual impairment, blindness and stroke if dermal filler accidentally enters a blood vessel. It would be inaccurate, however, to say that no dermal filler has FDA approval for any under-eye use: in 2023, the FDA approved Restylane Eyelight specifically for infraorbital hollowing. That product-specific approval does not cover other fillers, locations or PN injections, and does not establish their authorization in Armenia.

Sudden pain, blanching or gray-blue skin, loss of vision, double vision, a severe headache or neurological symptoms require immediate emergency medical assessment. They are not ordinary “a little swelling.” Increasing redness, warmth, discharge, fever or rapidly worsening swelling also calls for prompt clinical assessment for infection and other causes. Do not massage or inject substances into the affected area yourself.

Fish or seafood allergy calls for a separate check of the PN source and full formula: some PN ingredients are derived from fish. If you have such an allergy, postpone until a specialist has checked the official instructions and assessed suitability. Active infection, eyelid inflammation, unexplained swelling or a recent injection reaction calls for investigation first. Reliable safety data for elective cosmetic PN injections during pregnancy or breastfeeding are insufficient, so these procedures are usually deferred.

How can you aim for a natural outcome without taking needless risks?

“Natural” means different things to different people. One woman wants her gaze to remain recognizable, another needs to avoid a visible bruise, and another hopes for the blue shadow to disappear. With PN, the honest objective is a possible modest improvement in skin quality, not a dramatic new eyelid shape. Compare before-and-after images with matching expressions and light direction: a slightly higher chin or softer lighting can hide a hollow without any treatment.

For superficial dryness, adjusting care may be enough: stop irritating actives, avoid rubbing the eyelids, use a suitable moisturizer and protect the area from sun exposure. Pigmentation needs another plan; vascular shadows and anatomical hollows may not respond to “skin injections” at all. Botulinum toxin for movement-related lines, fillers for volume and eyelid surgery are separate decisions with their own contraindications. They should not be added automatically “for the full effect.” For more on the category, see polynucleotides and PDRN.

Consultation questions that can change the decision

Can you show me in the mirror what you intend to improve: fine lines, skin color or the shadow from the hollow?
What is the complete product name and formula, and is eyelid use permitted by the instructions in our country?
Are there independent studies of this exact formula in this exact area, rather than of the PN category alone?
What will be visible on day one and if I bruise; what should I do if an important event is soon?
Which symptoms require emergency help, and how can I access it after the clinic closes?
By what signs will we decide not to repeat the injections?

If the clinician does not distinguish pigmentation from a hollow, promises to “remove all circles” or will not show the packaging and instructions, a second opinion is reasonable. Declining or postponing injections is a complete decision. The eye area need not look identical morning and evening; small natural changes do not require correction merely because they have appeared.

Frequently asked questions

Can I receive PN if I previously had filler in my tear trough?

First tell the clinician the name and date of the filler and any reactions. Remaining material and a tendency to swell can change the plan; if needed, the clinician may request further tissue assessment. Starting a new course without sharing that information is unwise.

Do I need laboratory tests before cosmetic PN injections?

There is no single test panel for everyone. Any investigations depend on medical conditions, symptoms, medication and the intended product; unexplained dark circles or puffiness may call for medical diagnosis first.

Can only one side be treated if my asymmetry is slight?

This can be discussed only after identifying the reason for the asymmetry and checking the specific product's official instructions. Neither a symmetric schedule should automatically be applied to a one-sided concern nor identical tissue responses promised.